Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes

This study is currently recruiting participants.

Verified by University Hospital, Ghent, February 2009

First Received: December 4, 2005 Last Updated: February 12, 2009 History of Changes

Sponsors and Collaborators:	University Hospital, Ghent University Ghent
Information provided by:	University Hospital, Ghent
ClinicalTrials.gov Identifier:	NCT00263432

Purpose

Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries to obtain a repair and prevention of secondary osteoarthritis

Condition	Intervention
Cartilage Injuries in the Human Knee	Procedure: Human allogenic chondrocytes

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:

Healing of the cartilage injuries [ Time Frame: After 2 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment:

Arms	Assigned Interventions
1: Experimental Implantation of fresh human allogenic chondrocytes	Procedure: Human allogenic chondrocytes Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00263432

Contacts

Contact: Karl Fredrik Almqvist, MD, PhD

Locations

Belgium
University Hospital Ghent	Recruiting
Ghent, Belgium, 9000
Contact: Karl Fredrik Almqvist, MD, PhD fredrik.almqvist@UGent.be

Sponsors and Collaborators

University Hospital, Ghent

University Ghent

Investigators

Principal Investigator:

Karl Fredrik Almqvist, MD, PhD

University Hospital, Ghent

More Information

Additional Information:

Website of the University Hospital Ghent This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	University Hospital Ghent ( Karl Fredrik Almqvist, MD, PhD )
Study ID Numbers:	2001/245
Study First Received:	December 4, 2005
Last Updated:	February 12, 2009
ClinicalTrials.gov Identifier:	NCT00263432 History of Changes
Health Authority:	Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on August 30, 2009